99 Million People Included in Largest Global Vaccine Safety Study
Global Vaccine Data Network utilises vast data sets to detect potential vaccine safety signals 19 February 2024—The Global Vaccine Data Network (GVDN) assessed 13 neurological,
Global Vaccine Data Network utilises vast data sets to detect potential vaccine safety signals 19 February 2024—The Global Vaccine Data Network (GVDN) assessed 13 neurological,
The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the development of the
Need for developing case definitions and guidelines for abscess at injection site as an adverse events following immunization: An abscess at an injection site involving
The Coalition of Epidemic Preparedness Innovations (CEPI) has partnered with the Brighton Collaboration (BC), a program of the Task Force for Global Health, to support the harmonized safety
The ACIP met on April 20th to consider recommendations for a 2nd booster dose of mRNA COVID-19 vaccines. To download the CDC ACIP Meeting Report
Following the FDA approval of Moderna COVID-19 vaccine (Spikevax) for individuals 18 years and older on 31JAN2022, ACIP met today to review the complete package
Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2022, Advisory Committee on Immunization Practices
Need for developing a case definition and guidelines for data collection, analysis, and presentation for acute aseptic arthritis as an adverse event following immunisation (AEFI)
This post contains the Companion Guide for Acute Disseminated Encephalomyelitis (ADEM). This and other companion guides have been created as part of the CEPI-funded SPEAC project. They
This post contains the Companion Guide for Acute Encephalitis. This and other companion guides have been created as part of the CEPI-funded SPEAC project. They contain resources
Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030
